Ipsens, IQIRVO

Ipsen's IQIRVO Approval Has Intensified the Primary Biliary Cholangitis Market Space | DelveInsight

07.08.2025 - 18:06:43 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/ipsens-iqirvo-approval-has-intensified-the-primary-biliary-cholangitis-market-space--delveinsight-302265376.html

en | boerse | 67954036 |